Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer ; volume:17 ; number:1 ; day:7 ; month:11 ; year:2017 ; pages:1-16 ; date:12.2017
BMC cancer ; 17, Heft 1 (7.11.2017), 1-16, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Quintero, Melissa
- Beteiligte Personen und Organisationen
-
Adamoski, Douglas
Reis, Larissa Menezes dos
Ascenção, Carolline Fernanda Rodrigues
Oliveira, Krishina Ratna Sousa de
Gonçalves, Kaliandra de Almeida
Dias, Marília Meira
Carazzolle, Marcelo Falsarella
Dias, Sandra Martha Gomes
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3726-2
- URN
-
urn:nbn:de:1111-20180106673
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Quintero, Melissa
- Adamoski, Douglas
- Reis, Larissa Menezes dos
- Ascenção, Carolline Fernanda Rodrigues
- Oliveira, Krishina Ratna Sousa de
- Gonçalves, Kaliandra de Almeida
- Dias, Marília Meira
- Carazzolle, Marcelo Falsarella
- Dias, Sandra Martha Gomes
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Recent advances in therapeutic strategies for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
When human guanylate-binding proteins meet viral infections
Molecular mechanisms of human guanylate-binding protein complexes
Structural requirements for membrane binding of human guanylate-binding protein 1
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Recent advances in therapeutic strategies for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
When human guanylate-binding proteins meet viral infections
Molecular mechanisms of human guanylate-binding protein complexes
Structural requirements for membrane binding of human guanylate-binding protein 1
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer
Recent advances in therapeutic strategies for triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
Comparative study of triple-negative breast cancer lines to selected therapeutic treatments
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Exploiting Therapeutic Vulnerabilities in Triple-Negative Breast Cancer: Successes, Challenges, and Opportunities
AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer
EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
When human guanylate-binding proteins meet viral infections
Molecular mechanisms of human guanylate-binding protein complexes